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Metabolism plays a central role in cell physiology and provides the cellular machinery for building biomolecules
essential for growth. At the genome-scale, metabolism is made up of thousands of reactions interacting with
one another. Untangling this complexity is key to understand how cells respond to genetic, environmental
or therapeutic perturbations. Here we discuss the roles of two complementary strategies for the analysis of
genome-scale metabolic models: constraint-based methods, such as flux balance analysis, and network science.
Whereas constraint-based methods estimate metabolic flux on the basis of an optimization principle, network-
theoretic approaches reveal emergent properties of the global metabolic connectivity. We highlight how the
integration of both approaches promises to deliver insights on the structure and function of metabolic systems
with wide-ranging implications in basic discovery science, precision medicine and industrial biotechnology.
I. INTRODUCTION
Metabolism comprises the biochemical reactions that
convert nutrients into biomolecules and energy to sus-
tain cellular functions. Advances in high-throughput
screening technologies have enabled the quantitative
characterization of metabolites, proteins and nucleic
acids at the genome-scale, revealling previously un-
known links between metabolism and many other cel-
lular processes. For example, gene regulation1, signal
transduction2, immunity3 and epigenetic modifications4
have been shown to interact closely with metabolic path-
ways. The increasing availability of data and the funda-
mental roles of metabolism in various cellular phenotypes
have triggered a surge in metabolic research, together
with a revived need for computational tools to untangle
its complexity.
At the genome scale, metabolism is made of mul-
tiple interconnected reactions devoted to the synthesis
of specific biomolecules (e.g. proteins, lipids or nucleic
acids) and to the production of energy. The notion of
a metabolic pathway is typically employed to organize
sets of related reactions into functionally cohesive sub-
systems. Thus, lipid pathways, for example, are tradi-
tionally studied as distinct subsystems from amino acid
or aerobic respiration pathways. Although conveniently
descriptive, such a priori partitioning can obscure the
links between relevant layers of metabolic organization.
Furthermore, metabolic connectivity is not static but
actively responds and adapts to extracellular cues. In-
deed, through various layers of transcriptional, transla-
tional and post-translational regulation, metabolic path-
ways can be activated or shutdown depending on ex-
ternal perturbations. These metabolic adaptations un-
derpin fundamental biological processes, such as micro-
bial adaptations to growth conditions5,6 or the ability
of pathogens to rewire their metabolism and evade the
action of antimicrobial drugs7. Metabolic adaptations
are also thought to modulate the onset of complex dis-
eases such as cancer8,9, diabetes, Alzheimer’s, and oth-
ers10,11. As a result, there is a growing need for compu-
tational methods that go beyond classical pathway def-
initions and uncover hidden groupings and interactions
between metabolic components.
The complexity of metabolism12 has prompted the de-
velopment of a myriad of methods to analyse its con-
nectivity. For specific pathways, kinetic models based
on differential equations are widely employed to describe
the temporal dynamics of metabolic intermediates and
products13,14. At the genome scale, however, such kinetic
models face substantial challenges in their construction
and analysis15. The most widespread method for genome
scale modelling is Flux Balance Analysis16 (FBA), a pow-
erful framework to predict how metabolic fluxes are dis-
tributed on the reaction network under an optimization
principle, such as maximizing growth. Therefore, the
concept of a metabolic network in FBA refers to the
stoichiometric connectivity relating the enzymes and the
metabolites they catalyze. Such a definition, however, is
at odds with the discipline of network science17, in which
complex systems are mathematically described through
graphs that are amenable to computational and mathe-
matical analyses.
In this paper we discuss the relationship between FBA
and graph-based analyses of metabolism, and we high-
light the different perspectives they bring to the prob-
lem. On the one hand, FBA has been shown to usefully
predict metabolic activity in various environmental and
genetic contexts; on the other, network science can shed
light on the emergent properties of global metabolic con-
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2nectivity. As illustrated in Figure 1, both approaches
share a common basis in that they represent genome-scale
metabolism in terms of a stoichiometric matrix, yet they
offer different toolkits for analysis. In the following, we
discuss their advantages and caveats, and highlight the
need for integrated methods that combine flux optimisa-
tion with the topological and graph-theoretical methods
of network science.
II. GENOME-SCALE METABOLIC MODELLING
A widely adopted strategy for genome-scale modelling
is constraint-based analysis18, an umbrella term for vari-
ous algorithms that predict metabolic fluxes using opti-
mization principles. Most popular among these is Flux
Balance Analysis (FBA), which predicts metabolic fluxes
at steady state by solving the following optimization
problem:
maxv J(v)
subject to: Sv = 0
V mini ≤ vi ≤ V maxi , i = 1, . . . ,m,
(1)
where S is the n×m stoichiometry matrix for a system
with n metabolites and m reactions; v is a vector contain-
ing the m reaction fluxes; and (V mini , V maxi ) are bounds
on each flux. J(v) is the objective function and is suitably
chosen to describe the optimization principle assumed to
underpin the physiology of the particular organism un-
der study. In microbes, the most common choice for the
objective function is biomass production, in which case
J(v) = cT · v, i.e., J(v) is assumed to be a linear combi-
nation of specific biosynthetic fluxes describing biomass
output as given by the vector c. There exists a broad
range of dedicated FBA software packages19,20 and the
popularity of FBA has led to a myriad of extensions that
account for other complexities of cell physiology, such as
gene regulation21 and dynamic adaptations22,23, among
many others24.
Flux Balance Analysis has found applications in di-
verse domains, including cell biology25, metabolic en-
gineering26, microbiome studies27–29, and personalized
medicine30–32. A salient feature of FBA is its ability
to incorporate various types of ‘omics datasets into its
predictions. Various approaches have been developed for
this purpose33–40, most of which incorporate experimen-
tal data into the metabolic model through adjustments
of the stoichiometric matrix S or the flux bounds V mini
and V maxi in (1).
A popular use case of FBA is the identification of es-
sential genes, i.e., genes that severely impact cellular
growth when knocked out. Through simulation of gene
deletions, FBA can serve as a systematic tool for in sil-
ico screening of lethal mutations, and identification of
biomarkers and drug targets in disease41–47. A related
application of FBA is the study of metabolic robustness.
Since only a fraction of all metabolic reactions are essen-
tial in a given environment, knocking out non-essential
reactions often has little effect on the phenotype. This is
because many reactions have functional backups through
other pathways, so as to preserve cellular function in face
of perturbations. By providing insights into the reorgani-
zation of fluxes under different conditions, FBA can also
help improve our understanding of robustness to gene
knockouts16,48–51, gene mutations52 and different growth
conditions53.
One limitation of FBA is the crucial importance of the
objective function to be optimized, which needs to be
designed to represent cellular physiology. In microbes,
a common choice is maximization of growth rate, but
it is questionable whether this is a realistic cellular ob-
jective across organisms or in different growth condi-
tions54–56. Although the vast majority of FBA studies
rely on the maximization of cellular growth, other objec-
tive functions have been proposed, including maximiza-
tion of ATP production38 and minimization of substrate
uptake minimization42.
III. APPLICATIONS OF NETWORK SCIENCE IN
METABOLIC MODELLING
Network science represents complex systems as graphs
where the nodes describe the components of the sys-
tem and the edges describe interactions between com-
ponents. This general description provides a backbone
for the modelling of large, interconnected systems across
many disciplines, including biology, sociology, economics
and others17. There have been numerous attempts to
formalize the analysis of metabolism under the lens of
network science. Graph-theoretic concepts such as de-
gree distributions and centrality measures57–59 can reveal
structural features of the connectivity of the overall sys-
tem, while clustering algorithms can uncover substruc-
tures hidden in the network topology. Such tools can be
combined with the analysis of perturbations, such as dele-
tions of network nodes or edges48,60, which can represent
changes in the environment, gene knockouts, or therapeu-
tic drugs that target specific metabolic enzymes. Unlike
FBA, in which the analysis depends on the choice of a
specific objective function, network-theoretical methods
rely on the metabolic stoichiometry alone.
Metabolic modularity is an area where network sci-
ence has shown promising results. Intuitively, a network
module is a subset of the network containing nodes that
are more connected among themselves than to the rest of
the network. Numerous works have studied the modular-
ity of metabolic networks, and how the network modules
can be used to coarse-grain the metabolic network into
subunits58,61–64. The modules identified using network
analysis have been found to mirror the organization of
textbook biochemical pathways while uncovering novel
links and relationships between them65. A recurring
theme in these analyses is the bow-tie topology, whereby
a metabolic network can be divided into an input com-
ponent, an output component and a strongly connected
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FIG. 1. Strategies for the analysis of metabolism at the genome-scale. Starting from the metabolic stoichiometry,
network science and FBA provide alternative routes for the analysis of metabolic pathways. Common applications include the
study of metabolic robustness, gene essentiality and the impact of heterologous expression.
internal component. This architecture aligns well with an
intuitive understanding of metabolism, which comprises
nutrient uptake, waste production and secretion, and a
large number of internal cycles which produce biomass
and energy58,61–64,66.
Despite promising results in the analysis of modularity,
network science has achieved mixed success in metabolic
research. For example, from a network perspective it is
natural to assume that essential genes should be asso-
ciated with high centrality scores67–70. This idea draws
parallels from other domains, such as the internet and
social networks, where highly central nodes are deemed
critical for network connectivity. However, the correla-
tion between gene essentiality and node centrality are
weak, with various essential metabolites and reactions
exhibiting low centrality scores71,72, possibly as a result
of poorly connected nodes in pathways that supply re-
sources essential for growth73. Other studies have at-
tempted to resolve this problem with new network met-
rics specifically tailored to describe important features of
metabolism60,66,74,75.
A key challenge for the use of network science in
metabolic modelling is the lack of consensus on how to
build a graph from a metabolic model. For a network
with q nodes, the graph is encoded through the q× q ad-
jacency matrix A, which has an entry Aij 6= 0 if nodes i
and j are connected, and Aij = 0 otherwise. Depending
on how nodes and edges are defined, one can build dif-
ferent graphs for the same metabolic model described by
the stoichiometry matrix S in (1). For example, one can
build a graph where the nodes are metabolites and the
edges are reactions between them58,76. In this case the
adjacency matrix is
An×n = SˆSˆ
T
, (2)
where Sˆ is the binary version of the stoichiometry matrix
S (i.e. Sˆij = 1 when Sij 6= 0, and Sˆij = 0 otherwise).
Conversely, a graph where the nodes are reactions and
the edges describe the sharing of metabolites as reactants
or products77,78 has an adjacency matrix
Am×m = Sˆ
T Sˆ. (3)
One can also build bipartite graphs, where both metabo-
lites and reactions are nodes of different types79,80, or
even hypergraphs where an edge connects a set of reac-
tants to a set of products81,82. In addition, all of these
graphs can be directed/undirected (when the matrix A is
symmetric/asymmetric), or weighted/unweighted (where
the elements Aij can have weights encoding different
properties). Such modelling choices have a dramatic in-
fluence on the results and conclusions drawn from net-
work analyses78,83,84. For example, the existence of
power law degree distributions57 and the small-world
property59, two widespread concepts in network science,
have been disputed85,86 and attributed to specific ways
of constructing the metabolic network graph84,87.
A further limitation of graph-based analyses is their
ad hoc treatment of pool metabolites, e.g., H2O, ATP,
NADH and other enzymatic co-factors. Because pool
metabolites participate in a large number of reactions,
they distort and dominate the topological properties of
the network. A common approach to minimize this prob-
lem is to prune pool metabolites from the graph; yet
there is no accepted standard on how to do this or how
to mitigate the potential loss of information in so do-
ing58,77. Another challenge arises from the representation
of the reversibility of metabolic reactions in the graph.
Although all biochemical reactions are reversible, they
take one direction depending on the physiological condi-
tions. Graph-based studies either pre-define a direction
for the flux of the reaction, or they split them into for-
ward and backward components59,88. Neither of these
approaches is ideal: assigning the direction of a reaction
based on one condition may not generalize across other
4conditions, whereas incorporating bi-directional edges in-
creases the complexity of the analysis.
IV. INTEGRATING FLUX INFORMATION AND
NETWORK SCIENCE
As discussed, network-theoretical models of
metabolism can be built in multiple ways. Each
particular choice represents particular modelling as-
sumptions and caveats that shape the conclusions
that can be drawn from them. Recent work, however,
strongly suggests that integration of flux information
into network analyses offers a promising avenue to
address these challenges.
A well-established approach relies on the notion of Ele-
mentary Flux Modes (EFM)89. Roughly speaking, EFMs
are steady state flux vectors (i.e. satisfying Sv = 0) with a
minimal, unique set of fluxâĂŘcarrying reactions. EFMs
are nonâĂŘdecomposable steady-state pathways, in the
sense that if any of its contributing reactions is deleted,
the EFM will not be able to carry a steadyâĂŘstate
flux90. A key result is that every steady state flux distri-
bution can be represented as a non-negative linear combi-
nation of EFMs. A number of algorithms have been pro-
posed for the efficient enumeration of EFMs89. Some of
these algorithms exploit topological connectivity and flux
information simultaneously, e.g., by using graph-based
models to identify flux balanced pathways91; by enumer-
ating the pathways with minimum flux variability92; or
by dividing the steady state flux space into smaller, in-
dependent sub-modules93,94. A somewhat related strat-
egy utilizes the concept of flux coupling, first defined by
Burgard and colleagues95. Two reactions Ri and Rj are
said to be flux coupled if non-zero flux in one implies
a non-zero flux in the other. This can be summarized
in terms of the flux ratio Rij = vi/vj . Depending on
minimal and maximal values attainable by Rij , reactions
can be: uncoupled (Rij ∈ [0,∞)), directionally coupled
(Rij ∈ [0, k] or Rij ∈ [k,∞), with k a positive number),
or fully coupled (Rij = k). A reaction coupling graph
can then be built by adding an edge between Ri and Rj
with the direction of the edge depending on the type of
coupling. This graph has been successfully employed to
find hierarchical relations between groups of reactions96,
as well as to identify driver reactions involved in control
of metabolic activity97. Both EFM and flux coupling ap-
proaches can be employed to build graphs with stoichio-
metric information, but, importantly, they do not require
the optimization of a cellular objective, as in FBA.
Another strand of research has focused on combin-
ing FBA solutions with the construction of graph mod-
els. Such studies cover a wide range of methodologies
and applications, including the identification of biomark-
ers using flux and centrality analyses98; the detection
of metabolic drug targets in cancer with flux similarity
graphs99; the study of metabolic robustness100; and the
analysis of metabolite essentiality101,102. The integra-
tion of FBA and network-theoretic analyses can overcome
some of the ambiguities in the construction of graphs to
represent metabolic models. Flux values resolve the di-
rection of a reaction in a given physiological state and
can thus be employed to assign weights to the inter-
actions between nodes. Various studies have utilized
this idea to construct graphs with either metabolites as
nodes101,103,104 or reactions as nodes78,105. For example,
the mass flow graph proposed in Beguerisse et al78 uses
FBA solutions to weigh the edges of a reaction graph. If
reaction Ri produces a metabolite xk that is consumed by
Rj , then the weight of the edge between both reactions
is
wij =
∑
k
(mass flow of xk from Ri to Rj), (4)
where the sum acts on all the metabolites that are pro-
duced by Ri and consumed by Rj . The weights (4) are
directly computed from the stoichiometric matrix S and
a flux vector obtained with FBA. Different mass flow
graphs can be then computed for FBA solutions corre-
sponding to specific environmental or biological condi-
tions. Such mass flow graphs were combined with cen-
trality analyses and community detection algorithms to
reveal changes in the modular structure of Escherichia
coli metabolism in various growth media, and to iden-
tify structural changes in hepatocyte metabolism in a
metabolic disease affecting kidney function78.
V. DISCUSSION
Recent discoveries have led to a renewed interest in
the interplay of metabolism with other layers of the cel-
lular machinery1–4. Due to the complexity and scale of
metabolic reaction networks, computational methods are
essential to tease apart the influence of metabolic archi-
tectures on cellular function. Here we have discussed
the complementary roles of Flux Balance analysis and
network science in the analysis of metabolism at the
genome scale. Although both approaches start from the
metabolic stoichiometry (Figure 1), they differ in their
mathematical foundations and the type of predictions
they produce. FBA predictions can be accurate but their
effectiveness requires high quality ‘omics datasets. Net-
work theory, in contrast, requires nothing more than the
metabolic stoichiometry, yet can lead to misleading pre-
dictions depending on how the network graph is built.
As a result, so far FBA has led to more successful con-
nections with experimental results than network science.
When used in isolation, both FBA and network science
can be insufficient to understand changes in metabolic
connectivity triggered by physiological or environmen-
tal perturbations. The integration of FBA and network-
theoretical methods can close this gap in many applica-
tion domains. For example, with the rise of big data
in the life sciences, there is a growing interest in us-
ing metabolic signatures of patients to tailor treatments
5suited to their individual needs106. Computational meth-
ods can play a key role in detecting drug targets involved
in metabolic activity, and how their targeting can disrupt
metabolic connectivity. A particularly promising area is
cancer treatment, where there is considerable interest on
drugs that target specific metabolic enzymes107,108.
Another exciting application domain is industrial
biotechnology109, where so called “microbial cell facto-
ries” are engineered for production of commodity chemi-
cals and fine products110. In this field, FBA is widely em-
ployed for strain design, with the goal of finding combina-
tions of genetic interventions that maximize production
of a desired metabolite. A recent trend is to increase pro-
duction with synthetic biology tools and dynamic control
of gene expression111,112. This approach needs computa-
tional methods that capture the dynamic reallocation of
metabolic flux. Integrating FBA solutions with network
models can provide a versatile tool to identify suitable
genetic modifications for microbial strains with increased
production.
Further developments at the interface of FBA and net-
work science offer a novel way to explore the impact of
perturbations on metabolic connectivity. The flexibility
of FBA allows for the modelling of metabolic perturba-
tions of various kinds, including changes in growth condi-
tions, deletion of metabolic genes or the action of enzyme
inhibitors, whereas the application of graph-theoretical
tools from network theory can bring a broadened under-
standing of emergent properties of the overall system.
This flexibility is a key advantage and offers promising
potential to deploy network science tools across a range
of questions in basic science, biomedicine and industrial
biotechnology.
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